We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.29B
AUM Growth
+$523M
Cap. Flow
-$16.9M
Cap. Flow %
-0.18%
Top 10 Hldgs %
11%
Holding
1,517
New
127
Increased
342
Reduced
374
Closed
132

Top Buys

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$55M
2
MCK icon
McKesson
MCK
+$54M
3
EMN icon
Eastman Chemical
EMN
+$53.9M
4
AXP icon
American Express
AXP
+$51.7M
5
DINO icon
HF Sinclair
DINO
+$50.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$86.9M
2
AMAT icon
Applied Materials
AMAT
+$74M
3
S
Sprint Corporation
S
+$69.7M
4
HPQ icon
HP
HPQ
+$64.6M
5
CL icon
Colgate-Palmolive
CL
+$47.8M

Sector Composition

Rank Sector Weight
1 Financials 24.39%
2 Industrials 14.62%
3 Consumer Discretionary 11.98%
4 Technology 11.41%
5 Healthcare 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SES
1376
DELISTED
Synthesis Energy Systems Inc.
SES
$37K ﹤0.01%
1,597
-234
-13% -$6.03K
PZG icon
1377
Paramount Gold Nevada
PZG
$90.9M
$33K ﹤0.01%
+25,000
New +$31.8K
NVLN
1378
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$31K ﹤0.01%
10,000
YUMA
1379
DELISTED
Yuma Energy Inc
YUMA
$30K ﹤0.01%
1,685
RHE
1380
DELISTED
Regional Health Properties, Inc.
RHE
$27K ﹤0.01%
13,392
-1,666
-11% -$8.7K
RVP icon
1381
Retractable Technologies
RVP
$20.1M
$23K ﹤0.01%
34,200
HLTH
1382
DELISTED
Nobilis Health Corp.
HLTH
$20K ﹤0.01%
15,000
-25,000
-63% -$34.5K
BIOA
1383
DELISTED
BioAmber Inc.
BIOA
$14K ﹤0.01%
35,000
-166,700
-83% -$79.3K
CNXR
1384
DELISTED
Connecture, Inc.
CNXR
$12K ﹤0.01%
75,000
-210,200
-74% -$111K
BTX.WS
1385
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$2K ﹤0.01%
16,348
ADBE icon
1386
Adobe
ADBE
$105B
-42,700
Closed -$6.37M
ADSK icon
1387
Autodesk
ADSK
$51.8B
-226,400
Closed -$25.4M
AMSF icon
1388
AMERISAFE
AMSF
$562M
-23,300
Closed -$1.36M
AZTA icon
1389
Azenta
AZTA
$1.3B
-25,000
Closed -$759K
BW icon
1390
Babcock & Wilcox
BW
$1.18B
-1,000
Closed -$33K
CC icon
1391
Chemours
CC
$2.48B
-234,900
Closed -$11.9M
CDE icon
1392
Coeur Mining
CDE
$15.1B
-231,000
Closed -$2.12M
CIEN icon
1393
Ciena
CIEN
$46.8B
-18,100
Closed -$398K
CL icon
1394
Colgate-Palmolive
CL
$74.8B
-656,236
Closed -$47.8M
CLF icon
1395
Cleveland-Cliffs
CLF
$6.49B
-387,900
Closed -$2.77M
CLX icon
1396
Clorox
CLX
$12B
-323,055
Closed -$42.6M
COHR icon
1397
Coherent
COHR
$43.4B
-134,004
Closed -$5.51M
CTLP
1398
DELISTED
Cantaloupe
CTLP
-171,900
Closed -$1.07M
CVLT icon
1399
Commault Systems
CVLT
$4.98B
-4,700
Closed -$286K
CX icon
1400
Cemex
CX
$16.9B
-316,472
Closed -$2.87M

Similar funds

Bridgeway Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Bridgeway Capital Management held 1,517 positions worth $9.29B, up 6% from $8.76B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management's Q4 2017 filing shows 127 new, 342 increased, 374 reduced and 132 closed positions. Its largest new stake was McKesson: 364,650 shares worth $56.9M. The largest sale was Johnson & Johnson, an estimated $86.9M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Bridgeway Capital Management's largest Q4 2017 buy was McKesson: 364,650 shares worth $56.9M.
  • Bridgeway Capital Management added most to IQVIA in Q4 2017, an estimated $55M increase.
  • Bridgeway Capital Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $86.9M.
  • Bridgeway Capital Management fully exited Sprint Corporation in Q4 2017, selling an estimated $69.7M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.29B portfolio in Q4 2017.
  • Bridgeway Capital Management opened 127 new positions and closed 132 in Q4 2017.
  • Bridgeway Capital Management's portfolio value rose 6% quarter-over-quarter to $9.29B.

Based on Bridgeway Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.